Ranbaxy Settles With GSK Over Generic Migraine Drug
Ranbaxy Laboratories Ltd. said it has reached a settlement with GlaxoSmithKline Plc, putting a stop to any possible patent litigation over a generic version of GSK's migraine drug Imitrex....To view the full article, register now.
Already a subscriber? Click here to view full article